Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Manish Jaggi Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SICOM Ltd Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SICOM Ltd MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements), 2015
Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transactions for the year ended on March 31, 2019 Mangalam Drugs & Organics Ltd - 532637 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report27/05/2019 3 Name of the Certifying Firm ANKIT SETHI & ASSOCIATES 4 Name of the Certifying Individual ANKIT SETHI 5Membership TypeACS 6 Membership Number 25415 7 CP No. 11089 8 Whether any observations/qualification reported by the Secretarial Auditor ? Yes Mangalam Drugs & Organics Ltd - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance of provisions of Regulation 47 of the SEBI(Listing Obligations and Disclosure Requirements)Regulations, 2015, we are pleased to enclose copies each of Free Press Journal(English Daily)and Navshakti (Marathi Daily)both dated 10th May, 2019 in which Audited financial results of the company for the quarter and year ended 31st March, 2019, have been published. The aforesaid results have been approved by the Board of Directors in its meeting held on 09th May, 2019. This is for your information and records. Mangalam Drugs & Organics Ltd - 532637 - Results- Financial Results For March 31, 2019
In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith Audited Financial Results for the quarter and year ended 31st March, 2019 along with Auditors Report and the statement of Assets and Liabilities as at the year ended on March 31, 2019 in the prescribed format which have been taken on record and approved by the Board of Directors of the company in its meeting held today i.e. 09th May, 2019 at Mumbai. Kindly note that meeting of Board of Directors commenced at 4.00 P.M. and concluded at 5.35 P.M. Further please note that the company has made necessary arrangement to publish the same in newspapers as required under Listing Regulations. Kindly acknowledge the receipt and take the same on your records. Mangalam Drugs & Organics Ltd - 532637 - Outcome of Board Meeting
In terms of Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that, the meeting of Board of Directors was held today i.e. Thursday, 09th May, 2019 at 4.00 P.M at the time scheduled for the meeting at the registered office of the company, where in the following business was inter-alia transacted: 1.The Board of Directors considered and approved the Audited Financial Results/Statements for the quarter and year ended 31st March, 2019 ; 2. Noted the Resignation of Mr. Ajay Sawhney as an Independent Director of the Company with effect from 16th April, 2019 due to his personal reasons. 3. Other Business transacted with permission of chair. Kindly note that the meeting of the Board of Directors concluded at 5.35 P.M. You are requested to take the same on your records. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayMANGALAM DRUGS & ORGANICS LTD. 2CININE584F01014 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 8 4Highest Credit Rating during the previous FY BBB+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)INDIA RATINGS AND RESEARCH PVT. LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Nikita Bavishi Designation: Company Secretary EmailId: nikita@mangalamdrugs.com Name of the Chief Financial Officer: Ajay A Samant Designation: Chief Financial Officer EmailId: samant@mangalamdrugs.com Date: 30/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.